Meniere's Australia

Meniere's Australia Founded otogenex - early stage genomic bio-mark med-tech for precision, personal medicine. No affiliations to disclose. No one else was willing to do so.

Free updated info on hydropic inner ear disorders by Stephen Spring, former VP, Meniere's Research Fund Inc, Sydney Uni (closed 2008) and otoscience communicator. Free updated information about science of Meniere's Disease (hydropic inner ear disorders) and relevant otolaryngology. Unfortunately, advocacy services for Meniere's in Australia are no longer freely supported by the Australian Government. Posts, costs and upkeep by Stephen Spring, former VP of the Meniere's Research Fund Inc at Sydney University (dissolved and closed 2008). Disclosures: Stephen Spring is an otolaryngology science communicator and founder of otogenex, a private, early stage genomic and bio-marker service provider to the medical profession. History: Over 10 years ago the Meniere’s volunteer New South Wales and Victorian support groups who founded the research team at Sydney University combined to form Meniere’s Australia. The NSW face to face doctor patient meetings were cancelled. Meniere’s Australia then incorporated itself into a new brand “Whirled Foundation” to try to provide government funded support and advocacy services for Australians with MD and other vestibular orders. It said it was the national non-profit, non-government organisation for vestibular problem sufferers, but collapsed in 2018 which left no government funded advocacy service for Australian suffering with vestibular disorders. All documents and databases were lost or seized. Stephen Spring keeps this page open, personally pays for journals, upkeep and rights to the Meniere's Australia name.

Finding subsets and multidisciplinary approaches – lessons from the Australian experience.For many decades, the scientif...
01/10/2025

Finding subsets and multidisciplinary approaches – lessons from the Australian experience.

For many decades, the scientific community has known MD is an expression of a family of disorders of distinct subsets, with a common pathologic substrate of endolymphatic hydrops, a dilation of parts of the space occupied by seemingly too much endolymph.

The main pathologic feature compared to non MD controls is ultrastructural damage to the endolymphatic sac and duct. Animal models, despite limitations, can replicate symptoms with a similar pathology seen in humans. But hydrops in and of itself does not imply a diagnoses as the movement, production, absorption, composition and volume of endolymph is a dynamic, not a static process.

The idea that subsets initiate and lead to chronic hydrops might seem revolutionary, but it’s not, nor is it radical or novel. Since 1920s, it’s been known inner ears are affected in dyslipidosis, atopy, altered metabolism, failure of pneumatisation of the temporal bone, the absence, narrowing or enlargement of the vestibular aqueduct, stenosis of auditory meatus and/or can be secondary to immunological, vascular and infectious processes and can be otosclerotic, drug and injury induced and much more. The complexity of the inner ear and MD’s symptom variability, heterogeneity, multifactorial and individual nature means one mechanism initiating hydrops in one person is rarely exactly same as the next. Despite all that’s known, this subset idea has yet to find widespread use in the global clinic. In fact, new technology and other surgical or medical “breakthroughs” in MD has never been limited to simplistic answers or one size fits all.

Doctor Wilmot noted in his early 1980s book on “MD and its management” referring to Harrison and Naftalin’s 1968 book of MD, “…it takes twenty years of study to have a basic understanding of MD.” Wilmot said, “…the problem is something akin to backache where a few cases are due to genuine disc pathology requiring expert diagnosis and treatment but in which the vast majority are due to a multiplicity of factors that each need careful assessment and evaluation. Those who believe all backache is due to disk involvement are as incorrect as those who believe that all patients with deafness tinnitus and vertigo have MD; similarly those who deny the existence of MD as an entity are as incorrect as those who are reluctant to believe in genuine disc pathology…it would appear therefore that the frequent and repeated failure of each new approach [surgical or otherwise] is due to a misunderstanding of the basic causes of the condition [in any one individual].

In 1995, the Australian federal government created a special task force of medical experts to develop a Statement of Principles (SoP) for MD. A SoP acts like a legal definition that helps determine who qualifies for medical test, benefits, disability pensions, and insurance claims, guiding interested doctors making diagnoses and recommending appropriate tests and treatments based upon the latest research for personal and individual diagnoses and treatments.

Professor Lindsay Wing was head of ENT at Hobart Royal Hospital for three decades. At Sydney University, taught ENTs anatomy and about subsets in MD which he first published in 1979. He used a unique method of taking a sample of mucus and blood and measuring immunological and cytokine bio-markers. Now, in 2025, subset approaches with additional genetics are being re-discovered and will hopefully re-emerge for today’s personal and individual diagnoses and treatments.

The first true medical book written about MD was published in 1952 by HL Williams. A couple of low volume specialist MD ...
30/09/2025

The first true medical book written about MD was published in 1952 by HL Williams. A couple of low volume specialist MD books followed in the late 50s and early 60s, bringing together nearly a thousand separate studies and publications dating back to 1760 when Domenico Cotugno, at only 24 years described the endolymphatic sac and duct. His thesis suggested that structure was an aqueduct draining fluid from the inner ear and its dysfunction could cause symptoms such as phantom noises, a remarkable observation in his day.

It wasn't until 1861 Prosper Meniere (b. 18 June 1799) published about inner ear lesions and although ridiculed at the time, suggested that forms of epilepsy and migraine could stem from the inner ear and not the brain. Since that time, his name has become attached to a loose variety of clinical conditions presenting as vertigo, tinnitus and deafness.

Since 1920s, it’s been known inflammatory, neoplasms, atopy (1940s), injury and infectious and other processes involving the labyrinth, cochlea, 8th nerve, central connections and the endolymphatic sac can culminate in what became to be known as Meniere’s Disease. However, it wasn't until 1938 that Hallpike, Cairns and others established histological findings in human temporal bones indicative of the underlying pathology and thus the term Meniere’s Disease stuck, describing a series of different pathologies, now termed subsets. Publications by Mygind and Dederding in 1938-43 constituted the first biochemical approach to the basic understanding of those subsets and although lost to history, offered remarkable insights that endolymphatic hydrops is not a single disease.

Did you know?The world’s first medical research group dedicated to Meniere’s Disease (‘MD’) was the International Menier...
29/09/2025

Did you know?

The world’s first medical research group dedicated to Meniere’s Disease (‘MD’) was the International Meniere's Disease Research Institute (IMDRI) and Ear Center, Hampton Ave, Englewood, CO, USA in 1970s. It was founded by Dr Irv Arenberg who invented the Arenberg valve sometimes used in sac surgery procedures and the Prosper Meniere Society over 45 years ago. The first professional symposium was held on 14-21 August 1982.

In a 1969 paper, Arenberg’s group proposed that endolymphatic hydrops was the common final pathway of a family of distinct subsets of inner ear disease states. They built upon nearly a century of work analysing damaged endolymphatic sacs and ducts in those with MD compared to controls, first described in animal studies in 1919 and humans in mid 1920s. It is only recently that other groups have proposed the very same concept that MD is not a single disease: -

1. Clinical Subtyping of Meniere’s Disease (Phillips et al., 2018)
2. Meniere’s disease: new guidelines, subtypes, imaging, and more (Justin Hoskin, 2022)
3. Future Directions in Meniere Diagnosis and Treatment (Zhang et al., 2022)
4. A Modern Framework for Treating Meniere’s Disease (Chari et al., 2025)

Genetics and MD - a focus on the Stria Vascularis - A Systematic Review on the Role of the Stria Vascularis in Meniere’s...
25/09/2025

Genetics and MD - a focus on the Stria Vascularis -

A Systematic Review on the Role of the Stria Vascularis in Meniere’s Disease Pathogenesis Journal of the Association for Research in Otolaryngology

Purpose The stria vascularis (SV) is a secretory epithelium that maintains fluid homeostasis and generates the endocochlear potential in the cochlear duct. Multiomic studies have identified genes in the SV that could contribute to the pathogenesis of Menière’s Disease (MD), a disorder defined by ...

Vertigo education day in French...
25/09/2025

Vertigo education day in French...

Samedi 18 OCTOBRE 2025 ↓↓ Formulaire d'inscription en bas du programme ↓↓ Public : L’ensemble des professions intervenant dans la…

Webinar on MD (no sound) 19 September 2025. - IFOS 2025
22/09/2025

Webinar on MD (no sound) 19 September 2025. - IFOS 2025

This is "MD talk - 19 Sept 2025 - IFOS 2025" by Aust Retail Lease Management on Vimeo, the home for high quality videos and the people who love them.

The books of a century now boiled down to one slide in 2025
21/09/2025

The books of a century now boiled down to one slide in 2025

Did you know?The first conference or symposium on Meniere's disease was in 1967 at the Mayo clinic, but the first truly ...
20/09/2025

Did you know?

The first conference or symposium on Meniere's disease was in 1967 at the Mayo clinic, but the first truly International Symposium on Meniere's Disease was held in May, 1980, Dusseldorf, Germany with 8 countries and 36 presentations followed by the second International Symposium on Meniere's Disease held on June 20-22, 1988 in Boston, Massachusetts, USA with 300 participants,17 countries and 77 presentations.

The third International Symposium on Meniere's Disease was on October 20-23, 1993, Rome, Italy with 350 participants,13 countries and 112 presentations and the fourth International Symposium on Meniere's Disease on April 11-14, 1999, Paris, France with 400 participants,19 countries and 130 presentations. The fifth was in Los Angeles on April 2-5, 2005 with more than 140 presentations, the sixth International Symposium on Meniere's Disease was in Kyoto, Japan, from November 15-17, 2010 with over 400 attendees.

The seventh was in Rome on October 17-20, 2015 with over 500 attendees and a COVID delayed eighth conference and International Symposium on Meniere’s Disease and Inner Ear Disorders was held in Shanghai, China, from April 25–28, 2024.

The ninth International Symposium on Meniere’s Disease and Inner Ear Disorders will be held in Tokyo, Japan on February 24-27, 2027…

https://www.mediproduce.com/meniere2027/index.html

Dinner with Prof Gibson, and wives Alex and Caroline...
19/09/2025

Dinner with Prof Gibson, and wives Alex and Caroline...

A bit of bedtime reading...
11/09/2025

A bit of bedtime reading...

Professor Joseph Nadol passed away last month. He was a giant in the world of MD and the editor of the book from the 2nd...
11/09/2025

Professor Joseph Nadol passed away last month.

He was a giant in the world of MD and the editor of the book from the 2nd International Symposium on MD in 1988 and numerous other studies...sad, but best wishes to his family.

Just out, but nothing new! Synergistic role of blood-labyrinth barrier permeability and endolymphatic hydrops: a compara...
03/09/2025

Just out, but nothing new!

Synergistic role of blood-labyrinth barrier permeability and endolymphatic hydrops: a comparative perspective in Ménière’s disease and vestibular migraine.

Conclusion: Delayed gadolinium-enhanced MRI of the inner ear facilitates the differentiation between MD and VM. The combination of EH, SIR, and c-SIR AI demonstrates excellent diagnostic performance. Notably, elevated SIR shows the strongest correlation with high-frequency hearing impairment, while cochlear EH primarily contributes to low- and mid-frequency hearing loss. By integrating imaging findings with audiological profiles, clinicians can accurately characterize cochlear pathology, enabling the development of tailored treatment strategies.

https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1667277/full?fbclid=IwY2xjawMkwddleHRuA2FlbQIxMQBicmlkETFGcTFsc1Z4ckxWSE9iMGJWAR5Ii7xAr20AfjU_m0gOQXHCLKR8zUfrEDC3RhU0xAOJhroYX9GZyiUx3mXd6g_aem_Ull6c6GkdOfEHRMrWv4h4A

ObjectiveThis study compares the delayed gadolinium-enhanced MRI characteristics of Ménière’s disease (MD) and vestibular migraine (VM) to develop a multipar...

Address

PO BOX 295
Mosman, NSW
2088

Telephone

+61411500323

Website

http://stephenspringprotocol.com/

Alerts

Be the first to know and let us send you an email when Meniere's Australia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Meniere's Australia:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram